Endra Life Sciences Inc.
13F holders, Q3 2024 (September 30)11holders
$0.20avg. 13F price*
At the end of Q3 2024, 11 institutions reported holding Endra Life Sciences Inc. in their 13F filings. The largest holders were Virtu Financial LLC ($16K), Two Sigma Securities, LLC ($4K) and Tower Research Capital LLC (TRC) ($3K).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B401
- Latest filing quarter
- Q3 2024
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $33K |
| Exits | 0 | $0 |
Ownership 11 holders
| Virtu Financial LLC | 0.00% | New | 80,516 | $16K |
| Two Sigma Securities, LLC | 0.00% | New | 19,211 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 16,326 | $3K |
| Two Sigma Investments, LP | 0.00% | New | 14,175 | $3K |
| Jane Street Group, LLC | 0.00% | New | 11,213 | $2K |
| Jump Financial, LLC | 0.00% | New | 10,197 | $2K |
| HRT Financial LP | 0.00% | New | 13,848 | $2K |
| Morgan Stanley | 0.00% | New | 2,615 | $526 |
| NewEdge Advisors, LLC | 0.00% | New | 691 | $113 |
| Bank of America Corp. | 0.00% | New | 11 | $2 |
| Danske Bank A/S | 0.00% | New | 3 | $1 |
"% of holder's portfolio" is ENDRA LIFE SCIENCES INC's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.